During supine rest eight AGHD males ( 59.88 years , BMI 29.74.9 kg/m ( 2 ) ) were treated with one daily s.c. GH injections of 3 mg/24 h for 48 h ( treatment sessions A , B ) or a continuous s.c. GH infusion of 3 mg/24 h for 60 h ( treatment sessions C , D ) .